In breast cancer and rectal cancer specimen, MMP-2/-9 activation was observed to be enhanced in the tumor site in comparison to the adjacent healthy tissue, and correlated with dissemination, cancer progression and treatment outcome (69–71). This evidence concerns the gene MMP2 and cancer.